Global Cardiac Ablation Devices Market was valued at USD 2.25 billion in 2021

Global Cardiac Ablation Devices Market was valued at USD 2.25 billion in 2021, growing at a CAGR of 12.77% during the forecast period from 2022 to 2027, to reach USD 4.63 billion by 2027. The demand for Cardiac Ablation Devices is motivated by a rise in the prevalence of cardiovascular diseases like cardiac arrhythmia, atrial fibrillation, and stroke. Further, growth in new therapies, technological advancements, increasing geriatric population, and penetration and acceptance of Cardiac Ablation Devices in emerging countries will drive the market growth. Cardiac Ablation Devices were found to be extremely beneficial in heart failure cases in COVID-19 which further pushed for the demand for these devices in the pandemic situation.

Cardiac Ablation Devices Overview
Cardiac ablation is a surgical technique that can correct cardiac arrhythmias by scarring tiny regions of the heart. Cardiac arrhythmias arise where there is a deficiency of the electrical impulses that regulate the heartbeats. As a consequence, heartbeats are irregular and can lead to stroke or heart failure if left untreated, and are one of the main causes of death.

Download a PDF Sample Report- https://www.delveinsight.com/sample-request/cardiac-ablation-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Cardiac Ablation Devices Market Dynamics
Cardiac ablation is a surgical technique that can correct cardiac arrhythmias by scarring tiny regions of the heart. Cardiac arrhythmias arise where there is a deficiency of the electrical impulses that regulate the heartbeats. As a consequence, heartbeats are irregular and can lead to stroke or heart failure if left untreated, and are one of the main causes of death. The global demand for cardiac ablation devices is projected to record significant growth due to a rise in the geriatric population and an increase in the cardiovascular disease population base.

Recent Developmental Activities in the Cardiac Ablation Devices Market:
• In August 2021, the Stereotaxis and Shanghai Microport EP Medtech Co., Ltd. announced a broad collaboration to advance technology innovation and commercial adoption of robotics in electrophysiology in China. The agreement brings together MicroPort EP's commercial and product leadership in China's electrophysiology market with Stereotaxis' advanced Robotic Magnetic Navigation technology. MicroPort EP will also pursue regulatory approvals for Stereotaxis' latest innovations including the Genesis RMN® system and proprietary magnetic ablation catheter.
• In August 2021, Acutus Medical announced that its suite of new algorithms for the mapping and ablation of complex atrial arrhythmias received FDA clearance and CE mark approval.
• In June 2021, The FDA granted a new indication to a cryoballoon ablation catheter that allows it to be used as a first-line treatment for atrial fibrillation, before antiarrhythmic drugs. Until the new indication for the catheter (Arctic Front Advance, Medtronic), catheter ablation was approved only for use in patients with atrial fibrillation who had failed antiarrhythmic drug therapy.

Key Takeaways from the Cardiac Ablation Devices Market Report Study
• Market size analysis for current market size (2021), and market forecast for 5 years (2022-2027)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Cardiac Ablation Devices market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key companies dominating the Global Cardiac Ablation Devices Market.
• Various opportunities are available for the other competitor in the Cardiac Ablation Devices Market space.
• What are the top-performing segments in 2021? How these segments will perform in 2027?
• Which are the top-performing regions and countries in the current market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Cardiac Ablation Devices market growth in the coming future?

Cardiac Ablation Devices Market Segment Analysis
• Cardiac Ablation Devices by Technology (Radiofrequency (RF) Ablation, Electrical Ablation, Cryoablation, Ultrasound Ablation, Microwave Ablation)
• Cardiac Ablation Devices by Product (Radiofrequency (RF) Ablators [Temperature-Controlled Radiofrequency Ablators, Fluid-Cooled Radiofrequency Ablators, Robotic Catheter Manipulation Systems], Electrical Ablators [Argon Plasma/Beam Coagulators, Irreversible Electroporation Systems], Cryoablation Devices [Tissue Contact Probes, Others], Ultrasound Ablators [High-Intensity Focused Ultrasound Ablators, Ultrasound Ablation Systems, Others], Microwave Ablators [Microwave Thermotherapy Devices])
• Cardiac Ablation Devices Market By Application (Cardiac Rhythm Management, Open Surgery, Others)
• Cardiac Ablation Devices market by End User (Hospitals, Cardiac Centers, and Ambulatory Surgical Centers)
• Cardiac Ablation Devices market by Geography (North America, Europe, Asia-Pacific, and Rest of the World)
Discover more information about market report offering- https://www.delveinsight.com/report-store/cardiac-ablation-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Cardiac Ablation Devices Market Product Segment
Radiofrequency Ablators is expected to hold the largest share and it is one of the fastest-growing segments in the market. It is minimally invasive, enables excellent local tumor control, has promising long-term survival, and is a multimodal approach. Other factors such as lower cost of radiofrequency ablation, and ease of use will support the growth of the Cardiac Ablation Devices market globally. Further, the rising geriatric population will fuel the growth of the Cardiac Ablation Devices market.
Additionally, assistance from government bodies, favorable reimbursement scenarios, is expected to enhance the Cardiac Ablation Devices market potential in several countries. Hence, all the above-mentioned factors are expected to drive the segment growth.

Cardiac Ablation Devices Market Companies
Some of the key market players operating in the Cardiac Ablation Devices market include Abbott Laboratories, Boston Scientific Corporation, Avanos Medical, Inc., Auris Health, Inc., Olympus, CONMED Corporation, ERBE ELEKTROMEDIZIN GMBH, AngioDynamics, Medtronic Inc., AtriCure, Inc., Biosense Webster, Inc., Teleflex Incorporated, St. Jude Medical Inc., Lepu Medical Technology(Beijing)Co., Ltd., MicroPort Scientific Corporation, and others.

Request a PDF Sample Report- https://www.delveinsight.com/sample-request/cardiac-ablation-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of content
1. Cardiac Ablation Devices Market Report Introduction
2. Cardiac Ablation Devices Market Executive summary
3. Regulatory and Patent Analysis
4. Cardiac Ablation Devices Market Key factors analysis
5. Cardiac Ablation Devices Porter's Five Forces Analysis
6. COVID-19 Impact Analysis on Cardiac Ablation Devices Market
7. Cardiac Ablation Devices Market layout
8. Cardiac Ablation Devices Global Company Share Analysis - Key 3-5 Companies
9. Cardiac Ablation Devices Company and Product Profiles
10. Project Approach
11. KOL Views
12. DelveInsight Capabilities
13. Disclaimer
14. About DelveInsight

Do you have any query related to the report? If yes, click here- https://www.delveinsight.com/report-store/cardiac-ablation-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Contact Us
Yash
info@delveinsight.com

About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

This release was published on openPR.